Srisutham S, Saejeng A, Khantikul N, Sugaram R, Sangsri R, Dondorp A
Sci Rep. 2025; 15(1):4869.
PMID: 39929914
PMC: 11811204.
DOI: 10.1038/s41598-025-86630-7.
Ndiaye Y, Wong W, Thwing J, Schaffner S, Brenneman K, Tine A
Malar J. 2024; 23(1):205.
PMID: 38982475
PMC: 11234717.
DOI: 10.1186/s12936-024-05024-8.
Bakari C, Mandara C, Madebe R, Seth M, Ngasala B, Kamugisha E
Malar J. 2024; 23(1):71.
PMID: 38461239
PMC: 10924419.
DOI: 10.1186/s12936-024-04896-0.
Ndiaye Y, Wong W, Thwing J, Schaffner S, Tine A, Diallo M
medRxiv. 2023; .
PMID: 37163114
PMC: 10168519.
DOI: 10.1101/2023.04.24.23288820.
Kagoro F, Allen E, Mabuza A, Workman L, Magagula R, Kok G
Malar J. 2022; 21(1):207.
PMID: 35768869
PMC: 9244181.
DOI: 10.1186/s12936-022-04224-4.
Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018.
Dentinger C, Rakotomanga T, Rakotondrandriana A, Rakotoarisoa A, Rason M, Moriarty L
Malar J. 2021; 20(1):432.
PMID: 34732201
PMC: 8565026.
DOI: 10.1186/s12936-021-03935-4.
Molecular surveillance for polymorphisms associated with artemisinin-based combination therapy resistance in Plasmodium falciparum isolates collected in Mozambique, 2018.
Chidimatembue A, Svigel S, Mayor A, Aide P, Nhama A, Nhamussua L
Malar J. 2021; 20(1):398.
PMID: 34641867
PMC: 8507114.
DOI: 10.1186/s12936-021-03930-9.
Therapeutic Efficacy of Artemisinin-Based Combination Therapies in Democratic Republic of the Congo and Investigation of Molecular Markers of Antimalarial Resistance.
Moriarty L, Mandoko Nkoli P, Likwela J, Mitashi Mulopo P, Sompwe E, Matangila Rika J
Am J Trop Med Hyg. 2021; 105(4):1067-1075.
PMID: 34491220
PMC: 8592145.
DOI: 10.4269/ajtmh.21-0214.
Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014-2018.
Schmedes S, Patel D, Dhal S, Kelley J, Svigel S, Dimbu P
Emerg Infect Dis. 2021; 27(7):1902-1908.
PMID: 34152946
PMC: 8237877.
DOI: 10.3201/eid2707.203230.
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study.
Uwimana A, Umulisa N, Venkatesan M, Svigel S, Zhou Z, Munyaneza T
Lancet Infect Dis. 2021; 21(8):1120-1128.
PMID: 33864801
PMC: 10202849.
DOI: 10.1016/S1473-3099(21)00142-0.
Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in Angola.
Ebel E, Reis F, Petrov D, Beleza S
Malar J. 2021; 20(1):175.
PMID: 33827587
PMC: 8028775.
DOI: 10.1186/s12936-021-03713-2.
Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea.
Miotto O, Sekihara M, Tachibana S, Yamauchi M, Pearson R, Amato R
PLoS Pathog. 2020; 16(12):e1009133.
PMID: 33320907
PMC: 7771869.
DOI: 10.1371/journal.ppat.1009133.
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya.
Chebore W, Zhou Z, Westercamp N, Otieno K, Shi Y, Sergent S
Malar J. 2020; 19(1):291.
PMID: 32795367
PMC: 7427724.
DOI: 10.1186/s12936-020-03358-7.
Local emergence in Amazonia of C580Y mutants associated with artemisinin resistance.
Mathieu L, Cox H, Early A, Mok S, Lazrek Y, Paquet J
Elife. 2020; 9.
PMID: 32394893
PMC: 7217694.
DOI: 10.7554/eLife.51015.
High levels of imported asymptomatic malaria but limited local transmission in KwaZulu-Natal, a South African malaria-endemic province nearing malaria elimination.
Raman J, Gast L, Balawanth R, Tessema S, Brooke B, Maharaj R
Malar J. 2020; 19(1):152.
PMID: 32295590
PMC: 7161075.
DOI: 10.1186/s12936-020-03227-3.
Amplicon deep sequencing of kelch13 in Plasmodium falciparum isolates from Senegal.
Gaye A, Sy M, Ndiaye T, Siddle K, Park D, Deme A
Malar J. 2020; 19(1):134.
PMID: 32228566
PMC: 7106636.
DOI: 10.1186/s12936-020-03193-w.
Quantitative and rapid Plasmodium falciparum malaria diagnosis and artemisinin-resistance detection using a CMOS Lab-on-Chip platform.
Malpartida-Cardenas K, Miscourides N, Rodriguez-Manzano J, Yu L, Moser N, Baum J
Biosens Bioelectron. 2019; 145:111678.
PMID: 31541787
PMC: 7224984.
DOI: 10.1016/j.bios.2019.111678.
Rare mutations in Pfmdr1 gene of Plasmodium falciparum detected in clinical isolates from patients treated with anti-malarial drug in Nigeria.
Idowu A, Oyibo W, Bhattacharyya S, Khubbar M, Mendie U, Bumah V
Malar J. 2019; 18(1):319.
PMID: 31533729
PMC: 6751857.
DOI: 10.1186/s12936-019-2947-z.
Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018).
Raman J, Kagoro F, Mabuza A, Malatje G, Reid A, Frean J
Malar J. 2019; 18(1):280.
PMID: 31438951
PMC: 6704579.
DOI: 10.1186/s12936-019-2911-y.
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial.
Raman J, Allen E, Workman L, Mabuza A, Swanepoel H, Malatje G
Malar J. 2019; 18(1):209.
PMID: 31234865
PMC: 6592007.
DOI: 10.1186/s12936-019-2841-8.